In the news
Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes
Journal of Managed Care & Specialty Pharmacy (JMCP)
May 8, 2024Related news
In the news
July 12, 2024
Study Shows 85% Of Patients Discontinue GLP-1s For Weight Loss After 2 Years
Forbes
In the news
July 11, 2024
Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later
U.S. News & World Report